ELELYSO
Taliglucerase alfa
Listed by Pfizer Laboratories Div Pfizer Inc
- Strength
- 200 U/5mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Class
- Hydrolytic Lysosomal Glucocerebroside-specifi…
What it contains
- Taliglucerase Alfa 200 U/5mL
FDA record
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous |
| Drug class | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme |
| Approval route | BLA — biologic licence |
| NDC code | 0069-0106 |
| FDA application | BLA022458 |
| RxNorm concept | 1292879 |
| Package sizes listed | 1 |
| Marketed since | May 2012 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.